Locations:

Tag: steven nissen

August 18, 2015/Heart, Vascular and Thoracic/News & Insights

Approval of First PCSK9 Inhibitor Marks New Era (Video)

How it fits into today’s cholesterol-lowering practice

June 12, 2015/Heart, Vascular and Thoracic/Research

PCSK9 Inhibitors Edge Closer to FDA Approval

A new option for patients who need more than statins

March 5, 2015/Heart, Vascular and Thoracic/News & Insights

The Best of AHA 2014

Leading cardiologist picks studies with most impact

March 3, 2015/Heart, Vascular and Thoracic/News & Insights

No Advantage to Screening Asymptomatic Patients with CTA

Aggressive intervention fails to improve outcomes

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 29, 2015/Heart, Vascular and Thoracic/Research

Aspirin Fails to Prevent Cardiovascular Events in High-Risk Patients

Significant bleeding risk may outweigh any benefit

January 27, 2015/Heart, Vascular and Thoracic/Research

HDL Function Appears to Control Cholesterol-Lowering Ability

Amount of HDL may be less important than previously thought

January 22, 2015/Heart, Vascular and Thoracic/News & Insights

Longer Duration of Dual Antiplatelet Therapy Reduces Some Risks, Increases Others

A closer look at extended antiplatelet therapy

January 20, 2015/Heart, Vascular and Thoracic/News & Insights

Ezetimibe Adds Incremental Benefit to Statin Therapy

Further lowering LDL reduces risk in post-ACS patients

June 5, 2014/Heart, Vascular and Thoracic/Research

The Best of ACC 2014

A leading cardiologist weighs in on which presentations are likely to matter most to patient care

May 23, 2014/Heart, Vascular and Thoracic/Research

Poor POISE-2 Results Mean It’s Back to Square One

Neither clonidine nor aspirin protected surgery patients from cardiac complications

BackPage 4 of 5Next